Posted in Melanoma

Fecal Transplants May Improve Resistance to Melanoma Therapy

Posted by Geoff Beaty on 23 October 2021
Fecal Transplants May Improve Resistance to Melanoma Therapy
Studies have shown that the gut microbiota could influence the response of melanoma to anti–PD-1 immunotherapy. It is known that only 30%-40% of melanoma patients respond to anti–PD-1 immunotherapy, so the researchers focused on the gut microbiota of adult male patients. For the study, which was funded by the National Institutes of Health and published in Science, Professor Zarour and a team of colleagues, including Dr Diwakar Davar, MD, a Medical Oncologist/haematologist at...
Posted in:NewsEvidence Based ResearchCancerMelanoma  

Associations

  • The Institute for Functional Medicine
  • Society for Integrative Oncology
  • American Society of Clinical Oncology
  • Australian Traditional-Medicine Society
  • Naturopaths and Herbalists Association of Australia